Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases

BMC Palliative Care
Lourdes VicentManuel Martínez-Sellés

Abstract

Dyspnoea is a disabling symptom in patients admitted with heart failure (HF) and respiratory diseases (RD). The main aim of this study is to evaluate its intensity at admission and discharge and the relation with quality of life. We also describe its management, intensity, and evolution in HF and RD. In this descriptive, cross-sectional study, we included prospectively all patients admitted with decompensated HF and chronic obstructive pulmonary disease (COPD)/pulmonary fibrosis during 4 months. Surveys quantifying dyspnoea (Numerical Rating Scale 1-10) and quality of life (EuroQoL 5d) were administered at discharge. A total of 258 patients were included: 190 (73.6%) with HF and 68 (26.4%) with RD (62 COPD and 6 pulmonary fibrosis). Mean age was 74.0±1.2 years, and 157 (60.6%) were men. Dyspnoea before admission was 7.5±0.1. Patients with RD showed greater dyspnoea than those with HF both before admission (8.1±0.2 vs. 7.3±0.2, p=0.01) and at discharge (3.2±0.3 vs. 2.0±0.2, p=0.0001). They also presented a higher rate of severe dyspnoea (≥5) at discharge (23 [34.3%] vs. 36 [19.1%], p=0.02). Opioids were used in 41 (15.9%), mean dose 8.7±0.8 mg Morphine Equivalent Daily Dose. HF patients had worse EuroQoL 5d scores than those wit...Continue Reading

References

Aug 9, 2001·Annals of Medicine·R Rabin, F de Charro
Aug 10, 2001·Journal of Pain and Symptom Management·J PereiraE Bruera
Nov 28, 2002·European Journal of Heart Failure·M J JohnsonH J Dargie
Dec 14, 2004·Respiratory Medicine·Louise WatsonJoan B Soriano
Mar 3, 2007·Progress in Cardiovascular Diseases·Klaus K Witte, Andrew L Clark
Jul 31, 2007·Expert Opinion on Pharmacotherapy·John ParissisDimitrios T Kremastinos
Oct 24, 2007·Heart Failure Reviews·Peter A Shapiro
Apr 22, 2010·Current Opinion in Supportive and Palliative Care·Miriam J Johnson, Stephen G Oxberry
Nov 27, 2010·Heart Failure Clinics·Melvin R Echols, Wei Jiang
Feb 4, 2012·The Lancet Oncology·Augusto CaraceniUNKNOWN European Association for Palliative Care (EAPC)
Feb 18, 2012·American Journal of Respiratory and Critical Care Medicine·Mark B ParshallUNKNOWN American Thoracic Society Committee on Dyspnea
Aug 11, 2012·American Heart Journal·Stephen G OxberryMiriam J Johnson
Aug 11, 2012·American Journal of Respiratory and Critical Care Medicine·Jørgen VestboRoberto Rodriguez-Roisin
Jun 8, 2013·Journal of Pain and Symptom Management·Steffen T SimonRaymond Voltz
Jul 16, 2013·Maturitas·Anja HayenKyle T S Pattinson
Oct 12, 2013·The American Journal of Nursing·Kathy BakerRobert Banzett
Jul 16, 2015·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN Latin American Thoracic Association
Dec 2, 2015·Journal of Pain and Symptom Management·Ernest DiNinoPeter K Lindenauer

❮ Previous
Next ❯

Citations

Aug 21, 2019·The Veterinary Record·Alejandra I Arbe MontoyaMichelle L McArthur
Apr 8, 2020·Journal of Multidisciplinary Healthcare·Xavier Busquet-DuranPere Torán-Monserrat
Apr 20, 2018·Current Treatment Options in Cardiovascular Medicine·Abhinav SoodW H Wilson Tang
Dec 1, 2020·PharmacoEconomics·Gian Luca Di TannaGary Globe
Feb 27, 2021·Frontiers in Cardiovascular Medicine·Piotr Z SobanskiSarah J Goodlin
Mar 30, 2021·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Lyu WangXiuzhen Fan

❮ Previous
Next ❯

Software Mentioned

EuroQuol
STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.